As predicted from the bioinformatics analysis, the expression levels of miR-135b and miR-155 were upregulated in Luminal B, HER2+, and basal BC tissues compared with Luminal A BC (Figure 5B,C, respectively). This evidence concerns the gene ERBB2 and breast cancer.